Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzymotec Ltd (NASDAQ:ENZY)

8.91
Delayed Data
As of Jul 22
 +0.36 / +4.21%
Today’s Change
6.60
Today|||52-Week Range
10.70
-9.08%
Year-to-Date

Today’s Trading

Previous close8.55
Today’s open8.49
Day’s range8.39 - 8.98
Volume11,806
Average volume (3 months)49,100
Market cap$202.4M
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-16.67%
Earnings growth (this year)-19.44%
Earnings growth (next 5 years)+1.50%
Revenue growth (last year)+6.98%
P/E ratio--
Price/Sales4.53
Price/Book1.48

Competitors

 Today’s
change
Today’s
% change
CRISCuris Inc+0.02+1.27%
CBMGCellular Biomedicine...-0.18-1.27%
PFNXPfenex Inc+0.01+0.13%
RXDXIgnyta Inc-0.11-1.99%
Data as of 4:02pm ET, 07/22/2016

Financials

Next reporting dateAugust 10, 2016
EPS forecast (this quarter)$0.07
Annual revenue (last year)$50.4M
Annual profit (last year)$6.7M
Net profit margin13.26%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ariel Katz
Chief Financial Officer &
Vice President
Oren Bryan
Corporate headquarters
Migdal HaEmeq, Hazafon

Forecasts

Partner Offers

Search for Jobs